United Immunity, co., Ltd.
1 clinical trials · Sponsor
◉ Watch United Immunity, co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Study of UI-102 in Selected Advanced Cancers (NCT07605962) | United Immunity, co., Ltd. | 2026-05-20 |
Track United Immunity, co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.